GE HealthCare introduces elevated POC ultrasound solutions and new tablet-based Venue Sprint
Posted:
GE HealthCare announced the launch of enhanced Venue ultrasound systems and a new solution, setting the pace of point-of-care ultrasound (POCUS): Venue Sprint.
Read more in the MedTech Spectrum blog here.
The Food and Drug Administration approved a gene therapy for severe leukocyte adhesion deficiency type 1 (LAD-1), an ultra-rare disease that leaves children vulnerable to life-threatening infections.
Read more here.
OpenAI launched ChatGPT Health and Anthropic added medical toolsets for Claude, meaning users can sync their records and wearables, using their personal health data to get hyper-specific answers to their medical questions. At the same time, the FDA issued new guidance…